oxybutynin has been researched along with scopolamine hydrobromide in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 16 (66.67) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kurita, T; Park, YC; Sugiyama, T | 1 |
| Kirimoto, T; Matsuura, N; Nakano, K; Oka, T | 1 |
| Akira, T; Asano, K; Fujio, M; Inaba, K; Katayama, K; Sakashita, H; Sonda, S | 1 |
| Arbona, FL; Khabiri, B; Kover, AJ; Norton, JA | 1 |
| Baldwin, AD; DeSilva, P; Pieris, N; Wong, M | 1 |
| Becelli, R; Matarazzo, G; Morello, R; Renzi, G | 1 |
| Li Yim, J; Ng, J | 1 |
| Li, ST; Lin, CH; Lin, CY; Lung, HL | 1 |
| Kunst, A; Lee, G | 1 |
| Brandt, JC; Harman, E; Winchester, D | 1 |
| Chiu, HY; Dutkiewicz, EP; Urban, PL | 1 |
| Chowdhury, NA; Kim, H; Sewatsky, ML | 1 |
| Rosenbæk, JB | 1 |
| Farrell, N; Hack, J; Haronian, T; Zhang, XC | 1 |
| Cadwgan, J; Cole, M; Colver, AF; O'Hare, AE; Parr, JR; Pennington, L; Stocken, D; Todhunter, E; Tuffrey, C; Williams, J | 1 |
| Goncalves, M; Iro, H; Mantsopoulos, K | 1 |
| Brogden, NK; Fisher, J; Kandimalla, KK; Swaminathan, SK | 1 |
| Browning, M; Bukala, BR; Cowen, PJ; Harmer, CJ; Murphy, SE | 1 |
| Abolfotouh, MA; Al Jeraisy, M; AlFuraih, M; AlKhalifah, B; AlOtaibi, H; AlSaif, R | 1 |
| Bunge, AL; Delgado-Charro, MB; Guy, RH; Hattam, L; McGrogan, A; Pensado, A; White, KAJ | 1 |
| Joo, JH | 1 |
1 review(s) available for oxybutynin and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for oxybutynin and scopolamine hydrobromide
| Article | Year |
|---|---|
Use of scopolamine patches in patients treated with parotidectomy.
Topics: Adenoma, Pleomorphic; Combined Modality Therapy; Drainage; Humans; Parotid Gland; Parotid Neoplasms; Postoperative Complications; Scopolamine; Sweating, Gustatory; Transdermal Patch | 2014 |
Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Drug Administration Schedule; Female; Follow-Up Studies; Glycopyrrolate; Humans; Male; Nervous System Diseases; Prospective Studies; Scopolamine; Sialorrhea; Single-Blind Method; Transdermal Patch; Treatment Outcome | 2018 |
Overnight transdermal scopolamine patch administration has no clear effect on cognition and emotional processing in healthy volunteers.
Topics: Antidepressive Agents; Cognition; Double-Blind Method; Humans; Memory; Memory, Short-Term; Muscarinic Antagonists; Scopolamine; Transdermal Patch | 2019 |
20 other study(ies) available for oxybutynin and scopolamine hydrobromide
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Oxybutynin disrupts learning and memory in the rat passive avoidance response.
Topics: Administration, Oral; Animals; Avoidance Learning; Behavior, Animal; Cholinergic Antagonists; Dose-Response Relationship, Drug; Learning; Male; Mandelic Acids; Memory; Muscarinic Antagonists; Rats; Rats, Wistar; Reaction Time; Retention, Psychology; Scopolamine | 1999 |
Effects of antimuscarinic drugs on both urinary frequency and cognitive impairment in conscious, nonrestrained rats.
Topics: Administration, Oral; Animals; Basal Nucleus of Meynert; Benzilates; Cognition Disorders; Consciousness; Disease Models, Animal; Male; Mandelic Acids; Maze Learning; Muscarinic Antagonists; Parasympatholytics; Rats; Rats, Wistar; Scopolamine; Urinary Incontinence; Urination | 2001 |
1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.
Topics: Animals; Binding, Competitive; Cell Line; Humans; Indicators and Reagents; Insecta; Mandelic Acids; Muscarinic Antagonists; Oxepins; Rats; Receptor, Muscarinic M3; Salivary Glands; Scopolamine; Structure-Activity Relationship; Urinary Bladder, Neurogenic | 2007 |
Possible central anticholinergic syndrome following transdermal scopolamine in an ambulatory surgery patient.
Topics: Administration, Cutaneous; Adult; Ambulatory Surgical Procedures; Anesthesia Recovery Period; Cholinergic Antagonists; Female; Humans; Postoperative Nausea and Vomiting; Scopolamine; Syndrome; Transdermal Patch | 2011 |
Unequal pupils following removal of hyoscine patch.
Topics: Adolescent; Anisocoria; Antineoplastic Agents; Humans; Male; Mydriatics; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pupil; Scopolamine; Transdermal Patch | 2014 |
Accidental Unilateral Mydriasis from Hyoscine Patch in a Care Provider.
Topics: Accidents, Occupational; Female; Humans; Middle Aged; Mydriasis; Mydriatics; Nurses; Occupational Exposure; Scopolamine; Transdermal Patch | 2015 |
Delirium after transdermal scopolamine patch in two children.
Topics: Child; Child, Preschool; Cholinergic Antagonists; Delirium; Humans; Male; Motion Sickness; Scopolamine; Transdermal Patch | 2014 |
Measuring drug saturation solubility in thin polymer films: use of a thin acceptor layer.
Topics: Adhesives; Polymers; Scopolamine; Solubility; Transdermal Patch | 2015 |
An unusual case of nonsustained ventricular tachycardia.
Topics: Cholinergic Antagonists; Female; Humans; Middle Aged; Scopolamine; Tachycardia, Ventricular; Transdermal Patch | 2015 |
Micropatch-arrayed pads for non-invasive spatial and temporal profiling of topical drugs on skin surface.
Topics: Administration, Topical; Animals; Equipment Design; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Limit of Detection; Nicotine; Pharmaceutical Preparations; Printing, Three-Dimensional; Reproducibility of Results; Scopolamine; Skin; Specimen Handling; Spectrometry, Mass, Electrospray Ionization; Swine; Transdermal Patch | 2015 |
Transdermal Scopolamine Withdrawal Syndrome Case Report in the Pediatric Cerebral Palsy Population.
Topics: Adolescent; Antiemetics; Botulinum Toxins, Type A; Cerebral Palsy; Delayed Diagnosis; Humans; Injections, Subcutaneous; Lethargy; Male; Meclizine; Nausea; Neuromuscular Agents; Salivary Glands; Scopolamine; Sialorrhea; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; Vomiting | 2017 |
[Acute monosymptomatic anisocoria after removing a scopolamine patch from a patient].
Topics: Adult; Anisocoria; Female; Humans; Scopolamine; Transdermal Patch | 2017 |
Postoperative Anticholinergic Poisoning: Concealed Complications of a Commonly Used Medication.
Topics: Anticholinergic Syndrome; Cholinergic Antagonists; Dystonia; Emergency Service, Hospital; Female; Hallucinations; Humans; Meniscectomy; Middle Aged; Mydriasis; Postoperative Period; Scopolamine; Transdermal Patch | 2017 |
Transdermal scopolamine for the prevention of a salivary fistula after parotidectomy.
Topics: Cholinergic Antagonists; Female; Humans; Male; Parotid Gland; Parotid Neoplasms; Retrospective Studies; Salivary Gland Fistula; Scopolamine; Transdermal Patch | 2018 |
Development and validation of a sensitive LC-MS/MS method for the estimation of scopolamine in human serum.
Topics: Administration, Cutaneous; Adult; Antiemetics; Chromatography, High Pressure Liquid; Cross-Over Studies; Healthy Volunteers; Humans; Injections, Intravenous; Reproducibility of Results; Scopolamine; Solid Phase Extraction; Tandem Mass Spectrometry; Transdermal Patch | 2019 |
Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital.
Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Humans; Retrospective Studies; Saudi Arabia; Scopolamine; Sialorrhea; Tertiary Care Centers; Transdermal Patch | 2020 |
Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling.
Topics: Administration, Cutaneous; Adult; Biological Availability; Drug Delivery Systems; Female; Humans; Male; Models, Theoretical; Permeability; Scopolamine; Skin; Skin Absorption; Transdermal Patch | 2021 |
Anisocoria after scopolamine transdermal patch contamination: A case report.
Topics: Adult; Anisocoria; Female; Humans; Magnetic Resonance Imaging; Pilocarpine; Pupil; Scopolamine; Transdermal Patch | 2021 |